| The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. M Olivier, A Langer√∏ d, P Carrieri, J Bergh, S Klaar, J Eyfjord, ... Clinical cancer research: an official journal of the American Association …, 2006 | 699 | 2006 |
| Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription S Tuduri, L Crabbé, C Conti, H Tourrière, H Holtgreve-Grez, A Jauch, ... Nature cell biology 11 (11), 1315-1324, 2009 | 623 | 2009 |
| Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. C Escot, C Theillet, R Lidereau, F Spyratos, MH Champeme, J Gest, ... Proceedings of the National Academy of Sciences 83 (13), 4834-4838, 1986 | 617 | 1986 |
| EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ... Cell 115 (5), 523-535, 2003 | 536 | 2003 |
| Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia IU Ali, R Lidereau, C Theillet, R Callahan Science 238 (4824), 185-188, 1987 | 421 | 1987 |
| BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers J Adnane, P Gaudray, CA Dionne, G Crumley, M Jaye, J Schlessinger, ... Oncogene 6 (4), 659-663, 1991 | 345 | 1991 |
| Snail and slug play distinct roles during breast carcinoma progression C Côme, F Magnino, F Bibeau, P De Santa Barbara, KF Becker, C Theillet, ... Clinical cancer research 12 (18), 5395-5402, 2006 | 331 | 2006 |
| A refined molecular taxonomy of breast cancer M Guedj, L Marisa, A De Reynies, B Orsetti, R Schiappa, F Bibeau, ... Oncogene 31 (9), 1196-1206, 2012 | 328 | 2012 |
| Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups F Courjal, M Cuny, J Simony-Lafontaine, G Louason, P Speiser, ... Cancer research 57 (19), 4360-4367, 1997 | 297 | 1997 |
| In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. S Bautista, H Valles, RL Walker, S Anzick, R Zeillinger, P Meltzer, ... Clinical cancer research: an official journal of the American Association …, 1998 | 294 | 1998 |
| Loss of a c-H-ras-1 Allele and Aggressive Human Primary Breast Carcinomas C Theillet, R Lidereau, C Escot, P Hutzell, M Brunet, J Gest, J Schlom, ... Cancer research 46 (9), 4776-4781, 1986 | 278 | 1986 |
| Comprehensive profiling of 8p11-12 amplification in breast cancer V Gelsi-Boyer, B Orsetti, N Cervera, P Finetti, F Sircoulomb, C Rougé, ... Molecular Cancer Research 3 (12), 655-667, 2005 | 270 | 2005 |
| Protocols for an improved detection of point mutations by SSCP. L Spinardi, R Mazars, C Theillet Nucleic Acids Research 19 (14), 4009, 1991 | 242 | 1991 |
| Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors F Courjal, G Louason, P Speiser, D Katsaros, R Zeillinger, C Theillet International journal of cancer 69 (4), 247-253, 1996 | 237 | 1996 |
| A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer M Chanrion, V Negre, H Fontaine, N Salvetat, F Bibeau, GM Grogan, ... Clinical Cancer Research 14 (6), 1744-1752, 2008 | 220 | 2008 |
| p53 Mutations Occur in Aggressive Breast Cancer R Mazars, L Spinardi, M BenCheikh, J Simony-Lafontaine, P Jeanteur, ... Cancer research 52 (14), 3918-3923, 1992 | 211 | 1992 |
| Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene S El Messaoudi, E Fabbrizio, C Rodriguez, P Chuchana, L Fauquier, ... Proceedings of the National Academy of Sciences 103 (36), 13351-13356, 2006 | 210 | 2006 |
| Relating Genotype and Phenotype in Breast Cancer: An Analysis of the Prognostic Significance of Amplification at Eight Different Genes or Loci and of p53 Mutations M Cuny, A Kramar, F Courjal, V Johannsdottir, B Iacopetta, H Fontaine, ... Cancer research 60 (4), 1077-1083, 2000 | 210 | 2000 |
| TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains AL Børresen, TI Andersen, JE Eyfjörd, RS Cornelis, S Thorlacius, Å Borg, ... Genes, Chromosomes and Cancer 14 (1), 71-75, 1995 | 210 | 1995 |
| Proto-oncogene amplification and human breast tumor phenotype. J Adnane, P Gaudray, MP Simon, J Simony-Lafontaine, P Jeanteur, ... Oncogene 4 (11), 1389-1395, 1989 | 210 | 1989 |
